A detailed history of Mitchell Sinkler & Starr transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Mitchell Sinkler & Starr holds 3,030 shares of XBI stock, worth $276,457. This represents 0.07% of its overall portfolio holdings.

Number of Shares
3,030
Previous 2,170 39.63%
Holding current value
$276,457
Previous $201,000 48.76%
% of portfolio
0.07%
Previous 0.05%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$90.87 - $102.43 $78,148 - $88,089
860 Added 39.63%
3,030 $299,000
Q2 2024

Aug 07, 2024

BUY
$82.22 - $94.12 $44,563 - $51,013
542 Added 33.29%
2,170 $201,000
Q1 2024

Apr 30, 2024

SELL
$87.05 - $102.89 $513,333 - $606,742
-5,897 Reduced 78.37%
1,628 $154,000
Q4 2023

Feb 12, 2024

BUY
$64.12 - $90.86 $482,503 - $683,721
7,525 New
7,525 $671,000
Q2 2023

Jul 18, 2023

SELL
$75.38 - $90.23 $11,307 - $13,534
-150 Reduced 2.46%
5,955 $495,000
Q1 2023

May 15, 2023

BUY
$73.13 - $91.97 $45,121 - $56,745
617 Added 11.24%
6,105 $465,000
Q4 2022

Feb 14, 2023

BUY
$76.72 - $85.66 $9,590 - $10,707
125 Added 2.33%
5,488 $455,000
Q3 2022

Oct 25, 2022

BUY
$75.06 - $94.9 $49,539 - $62,634
660 Added 14.03%
5,363 $425,000
Q2 2022

Jul 21, 2022

SELL
$62.81 - $96.09 $5,024 - $7,687
-80 Reduced 1.67%
4,703 $349,000
Q1 2022

Apr 19, 2022

BUY
$81.07 - $115.44 $53,100 - $75,613
655 Added 15.87%
4,783 $430,000
Q4 2021

Feb 01, 2022

SELL
$108.77 - $134.15 $36,981 - $45,611
-340 Reduced 7.61%
4,128 $462,000
Q3 2021

Oct 12, 2021

BUY
$118.69 - $138.49 $38,336 - $44,732
323 Added 7.79%
4,468 $562,000
Q2 2021

Jul 15, 2021

BUY
$122.48 - $139.69 $45,930 - $52,383
375 Added 9.95%
4,145 $561,000
Q3 2020

Oct 07, 2020

BUY
$103.87 - $120.36 $23,890 - $27,682
230 Added 6.5%
3,770 $420,000
Q1 2020

Apr 07, 2020

SELL
$65.95 - $98.35 $39,570 - $59,010
-600 Reduced 14.49%
3,540 $274,000
Q3 2019

Nov 06, 2019

SELL
$76.25 - $83.86 $202,062 - $222,229
-2,650 Reduced 39.03%
4,140 $316,000
Q2 2019

Jul 17, 2019

BUY
N/A
600 Added 9.69%
6,790 $596,000
Q4 2018

Jan 24, 2019

BUY
N/A
150 Added 2.48%
6,190 $444,000
Q3 2018

Oct 04, 2018

BUY
N/A
750 Added 14.18%
6,040 $579,000
Q2 2018

Jul 11, 2018

BUY
N/A
5,290 New
5,290 $504,000

Others Institutions Holding XBI

About SPDR SER TR SPDR S&P BIOTECH E


  • Ticker XBI
  • Sector ETFs
  • Industry ETFs
More about XBI
Track This Portfolio

Track Mitchell Sinkler & Starr Portfolio

Follow Mitchell Sinkler & Starr and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitchell Sinkler & Starr, based on Form 13F filings with the SEC.

News

Stay updated on Mitchell Sinkler & Starr with notifications on news.